Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines - Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines

Chest

Volumn 141, Issue 2 SUPPL., 2012, Pages 53S-70S

  Guyatt, Gordon H ^a   Norris, Susan L ^b   Schulman, Sam ^a   Hirsh, Jack ^a   Eckman, Mark H ^c   Akl, Elie A ^a,d   Crowther, Mark ^a   Vandvik, Per Olav ^e   Eikelboom, John W ^a   McDonagh, Marian S ^b   Lewis, Sandra Zelman ^f   Gutterman, David D ^g   Cook, Deborah J ^a   Schünemann, Holger J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e INNLANDET HOSPITAL TRUST   (Norway)

^f American College of Chest Physicians   (United States)

^g MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; ARGATROBAN; CLOPIDOGREL; DANAPAROID; FONDAPARINUX; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; PLACEBO; PRASUGREL; WARFARIN;

ANTICOAGULANT THERAPY; BIBLIOGRAPHIC DATABASE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CONFLICT; CONFLICT OF INTEREST; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; EVIDENCE BASED PRACTICE; FINANCE; FINANCIAL CONFLICT; HEART ATRIUM FIBRILLATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; META ANALYSIS (TOPIC); METHODOLOGY; MORTALITY; OUTCOMES RESEARCH; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY ADJUSTED LIFE YEAR; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE ALLOCATION; REVIEW; RISK REDUCTION; STROKE; SUPERFICIAL VEIN THROMBOSIS; SYSTEMATIC ERROR; THROMBOSIS; THROMBOSIS PREVENTION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 84856705100     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2288     Document Type: Article

References (41)

1. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ; American College of Chest Physicians. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl 6):110S-112S. (Pubitemid 351892962)
2. Guyatt GH, Oxman AD, Vist GE, et al GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-926. (Pubitemid 351632017)
3. Guyatt GH, Eikelboom JW, Gould MK, et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2) (suppl):e185S-e194S.
4. Guyatt G, Montori V, Devereaux PJ, Schünemann H, Bhandari M. Patients at the center: in our practice, and in our use of language. ACP J Club. 2004;140(1):A11-A12.
5. Ferreira-González I, Busse JW, Heels-Ansdell D, et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ. 2007;334(7597):786.
6. Ferreira-González I, Permanyer-Miralda G, Busse JW, et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J Clin Epidemiol. 2007;60(7):651-662.
7. Montori VM, Permanyer-Miralda G, Ferreira-González I, et al. Validity of composite end points in clinical trials. BMJ. 2005;330(7491):594- 596. (Pubitemid 40380357)
8. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guide lines. Chest. 2012;141(2)(suppl):e278S-e325S.
9. Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62(10): 1013-1020.
10. Oxman AD, Guyatt GH, Singer J, et al. Agreement among reviewers of review articles. J Clin Epidemiol. 1991; 44(1): 91-98.
11. Higgins JP, Altman D. Assessing the risk of bias in included studies. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Chichester, England: John Wiley & Sons; 2008:17-21.
12. Decousus H, Prandoni P, Mismetti P, et al CALISTO Study Group. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010;363 (13):1222-1232.
13. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100: 3484-3488. (Pubitemid 35303914)
14. Beyth RJ, Cohen AM, Landefeld CS. Long-term outcomes of deep-vein thrombosis. Arch Intern Med. 1995;155: 1031-1037.
15. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164:17-26. (Pubitemid 38067385)
16. Lewis BE, Wallis DE, Berkowitz SD, et al. A rgatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia . Circulation. 2001; 103:1838-1843. (Pubitemid 32328395)
17. Lewis BE, Wallis DE, Leya F, et al. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med. 2003;163:1849-1856. (Pubitemid 36960936)
18. Lubenow N, Eichler P, Lietz T, et al. Lepirudin in patients with heparin-induced thrombocytopenia-results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost. 2005;3 : 2428-2436. (Pubitemid 41727158)
19. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ; GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336(7651):995-998. (Pubitemid 351656090)
20. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med. 2002;21(11):1575-1600. (Pubitemid 34746064)
21. Furukawa TA, Guyatt GH, Griffith LE. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol. 2002;31(1):72-76. (Pubitemid 34284903)
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327 (7414):557-560. (Pubitemid 37088507)
23. Guyatt GH, Oxman AD, Kunz R, et al GRADE Working Group. Going from evidence to recommendations. BMJ. 2008;336(7652):1049-1051.
24. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001-2015. (Pubitemid 350106708)
25. Brozek J, Oxman A, Schünemann HS. GRADEpro [Computer program]. Version 3.2 for Windows, 2008. http://www.cc-ims. net/gradepro. or http://mcmaster.flintbox.com/technology. asp?page 5 3993.
26. MacLean S, Mulla S, Akl EA, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141(2)(suppl):e1S-e23S.
27. Guyatt G, Baumann M, Pauker S, et al. Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest. 2006;129(1):182-187. (Pubitemid 43265260)
28. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990;113(2):147-154. (Pubitemid 20218632)
29. Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1997;277(19):1552-1557. (Pubitemid 27213306)
30. O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA. 1997;277(22):1802-1806. (Pubitemid 27247167)
31. Eisenberg JM. Clinical economics. A guide to the economic analysis of clinical practices. JAMA. 1989;262(20):2879-2886. (Pubitemid 20002550)
32. Gold MR, Siegel JE, Russell LB, et al. Cost-Effectiveness in Health and Medicine. 1st ed. New York, NY:Oxford University Press; 1996.
33. Guyatt GH, Oxman AD, Kunz R, et al GRADE Working Group. Incorporating considerations of resources use into grading recommendations. BMJ. 2008;336(7654):1170-1173. (Pubitemid 351809277)
34. World Economic Outlook Database-April 2011:International Monetary Fund. World Health Organization Web site. http:// www.who.int/macrohealth/documents/ tough-choices/en/ index.html. Accessed June 27, 2011.
35. Hutubessy R, Chisholm D, Edejer TT. Generalized costeffectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003;1(1):8.
36. WHO Commission on Macroeconomics and Health. Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health: Executive Summary. Geneva, Switzerland: World Health Organization; 2001.
37. World Health Organization. Threshold Values for Intervention Cost-Effectiveness by Region. Geneva, Switzerland:World Health Organization; 2010.
38. Guyatt G, Akl EA, Hirsh J, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11):738- 741.
39. Jaeschke R, Guyatt GH, Dellinger P, et al GRADE Working Group. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008;337: a744.
40. Guyatt GH, Akl EA, Crowther M, Schünemann HJ, Gutterman DD, Lewis SZ. Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(suppl):48S-52S.
41. Ubel PA, Angott AM, Zikmund-Fisher BJ. Physicians recommend different treatments for patients than they would choose for themselves. Arch Intern Med. 2011; 171 (7):630-634.